Chief Strategy Officer, Head of Real-World Evidence & Safety Data Analytics
Dr. Marc Pignot joined ZEG Berlin to lead the implementation and development of Real-World Evidence & Safety Data Analytics.
Marc has more than 20 years of experience in the pharmaceutical and CRO business. As Chief Strategy Officer, he is establishing a strong secondary data stream to complement and combine with ZEG Berlin’s long-established primary data business. Real-World Evidence and services bridge the growing need for leading-edge secondary data collection with ZEG Berlin’s classical studies for post-authorization, safety, and effectiveness.
Marc Pignot served as Director of Real-World Evidence, and global consulting at Kantar Health, and as a Director at Kendle, now Syneos Health, a global CRO. He was responsible for conducting global clinical trials and Late Phase programs in the main therapeutic areas.
He also worked on Diagnostic Imaging and Medical Device Studies at Amersham Health and GE Healthcare. Before moving to clinical research, Marc worked with Aventis Pharmaceutical’s global research center focusing on functional genomics and proteomics.
Marc Pignot holds a PhD in Bio-Organic Chemistry from the Max Planck Institute of Molecular Physiology and completed postdoctoral training in nucleic acid chemistry at the University of Frankfurt/Scripps Research Institute (La Jolla).